Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data
| Autor: | Cho, Hyunjeong, Yoo, Ki Young, Shin, Ju-Young, Lee, Eun-Kyoung, Choi, BongKyoo |
|---|---|
| Zdroj: | In Journal of Thrombosis and Haemostasis June 2024 22(6):1640-1648 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|